Srini Tenjarla
SVP, CMC & Formulation · Serina Therapeutics, Inc.
Individual
- 2026
- May 26, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Srini Tenjarla files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Randall Moreadith - $377K in SER purchases and sales in the last 12 months
- Karen J. Wilson - $55K in SER purchases and sales in the last 12 months
- Richard Peter Marshall - $20K in SER purchases and sales in the last 12 months
- Stephen K. Brannan - $2K in SER purchases and sales in the last 12 months
- Jay Venkatesan - $1K in SER purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Srini Tenjarla?
Srini Tenjarla is a corporate insider, tracked as SVP, CMC & Formulation of Serina Therapeutics, Inc. (SER). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Srini Tenjarla last file a Form 4?
The most recent primary Form 4 on record is dated 26 May 2026, one of 2 filings going back to 2026.